160 related articles for article (PubMed ID: 21945644)
1. Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.
Thakur A; Scheinman RI; Rao VR; Kompella UB
Microvasc Res; 2011 Nov; 82(3):346-50. PubMed ID: 21945644
[TBL] [Abstract][Full Text] [Related]
2. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR).
Rao VR; Prescott E; Shelke NB; Trivedi R; Thomas P; Struble C; Gadek T; O'Neill CA; Kompella UB
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5198-204. PubMed ID: 20445119
[TBL] [Abstract][Full Text] [Related]
3. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
4. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
6. Effect of diabetes on transscleral delivery of celecoxib.
Cheruvu NP; Amrite AC; Kompella UB
Pharm Res; 2009 Feb; 26(2):404-14. PubMed ID: 18987961
[TBL] [Abstract][Full Text] [Related]
7. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
9. Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide.
Kinoshita N; Kakehashi A; Inoda S; Itou Y; Kuroki M; Yasu T; Kawakami M; Kanazawa Y
Diabetologia; 2002 May; 45(5):735-9. PubMed ID: 12107755
[TBL] [Abstract][Full Text] [Related]
10. Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.
Iwase T; Oveson BC; Hashida N; Lima e Silva R; Shen J; Krauss AH; Gale DC; Adamson P; Campochiaro PA
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):503-11. PubMed ID: 23169884
[TBL] [Abstract][Full Text] [Related]
11. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
12. Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA
Acharya NK; Qi X; Goldwaser EL; Godsey GA; Wu H; Kosciuk MC; Freeman TA; Macphee CH; Wilensky RL; Venkataraman V; Nagele RG
Diab Vasc Dis Res; 2017 May; 14(3):200-213. PubMed ID: 28301218
[TBL] [Abstract][Full Text] [Related]
13. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Tpl2 (Tumor Progression Locus 2) Inhibition on Diabetic Vasculopathy Through the Blockage of the Inflammasome Complex.
Sheu WH; Lin KH; Wang JS; Lai DW; Lee WJ; Lin FY; Chen PH; Chen CH; Yeh HY; Wu SM; Shen CC; Lee MR; Liu SH; Sheu ML
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e46-e62. PubMed ID: 33176446
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.
Jiang H; Zhang H; Jiang X; Wu S
Diabetologia; 2021 Mar; 64(3):693-706. PubMed ID: 33319325
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy.
Song B; Kim D; Nguyen NH; Roy S
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5965-5972. PubMed ID: 30550614
[TBL] [Abstract][Full Text] [Related]
18. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.
Miyamoto K; Khosrof S; Bursell SE; Rohan R; Murata T; Clermont AC; Aiello LP; Ogura Y; Adamis AP
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10836-41. PubMed ID: 10485912
[TBL] [Abstract][Full Text] [Related]
19. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2003 Jan; 458(3):283-9. PubMed ID: 12504784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
